Skip to content

Study of Skin and Role of Ayurveda medication in Yuvanpidaka.

A Physiological Study of Twak Sharir with special reference to Role of Kusthadi Lepa and Jalaukavacharana along with Manjishtha Churna in Yuvanpidaka.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/032883
Enrollment
40
Registered
2021-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

Intervention1: Manjistha Churna and Jalaukavacharana: Manjistha Churna- dose 3 gm with lukewarm water, orally, twice a day for 30 days Intervention2: Manjishtha Churna and Kusthadi Lepa: Manjistha Chu

Sponsors

National institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient willing to undergo trial and ready to give informed consent(In case of minor patients, i.e. age will be given by Parents/Guardian/Attendant) 2. Patients are either sex. 3. Patient in the age group of 16-40 years. 4. Patient with sign and symptoms of Yuvanpidaka . 5. Patient fit for Jalukavacharana.

Exclusion criteria

Exclusion criteria: 1. Known case of any Acute / chronic skin diseases like Psoriasis, Vitiligo, Dermatitis etc. 2. Known case of any genetic skin disorder, chronic systemic diseases, Sexually Transmitted Disease, Diabetes Mellitus, Hypertension, any blood disorders or any organ failure.

Design outcomes

Primary

MeasureTime frame
Changes in Global Acne Grading System.Timepoint: At Baseline(0th day),15th, and 30th day

Secondary

MeasureTime frame
Relief in classical sign and symptoms(Kandu, Ruja, Daha, Shrava, Snigdhata, Vaivarnya), Increase in Varnyaprasadan, Prabha vriddhi. Timepoint: will be done after 15 days of completion of treatment in all group.

Countries

India

Contacts

Public ContactNilkanth Upadhyaya

National Institute of Ayurveda, Jaipur

dr.yadavcr@gmail.com9460866101

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026